Pharmaceutical Raw Materials
Veterinary API
Pharmaceutical Intermediates
Biochemicals
Pharmaceutical Excipients
Other Chemical Drugs
Blood System Drugs
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Antibiotics
Synthetic Anti Infective Drugs
Antipyretic Analgesics
Antiallergic Drugs
Fluid, Electrolyte, and Acid-Base Balance
Vitamins and Minerals Medicines
Urinary System Drugs
Digestive System Drugs
Antiparasitic Drugs
Anesthetic Agents
Hormones and Endocrine Drugs
Diagnostic Agents
Circulatory System Drugs
Immune System Medication
Anti Stress Drugs
Inhibitors
Drug Metabolism
Specialty Drugs
Feed Drug Additive
CAS:364782-34-3
Molecular Formula:C22H23ClF3N
Alias
More Information
Mimpara; Sensipar; Cinacalcet Hcl; (R)-N-(1-(Naphthalen-1-Yl)Ethyl)-3-(3-(Trifluoromethyl)Phenyl)Propan-1-Amine Hydrochloride; (Ar)-A-Methyl-N-[3-[3-(Trifluoromethyl)Phenyl)Propyl]-1-Napthalenemethanamine Hydrochloride; N-[(1R)-1-Naphthalen-1-Ylethyl]-3-[3-(Trifluoromethyl)Phenyl]Propan-1-Amine Hydrochloride; -Naphthalenemethanamine, .Alpha.-Methyl-N-[3-[3-(Trifluoromethyl)Phenyl]Propyl]-, Hydrochloride
Brief Introduction
Cinacalcet Hydrochloride is a specific drug for controlling hyperparathyroidism and inhibiting parathyroid hormone PTH.
Suppliers
View More Vendors (2） >
Yangzhou Qinyuan Pharmaceutical Technology Co.,Ltd.
99.5%
/
-
Alias
More Information
1-(4-Methoxyphenyl)-7-Oxo-6-[4-(2-Oxopiperidin-1-Yl)Phenyl]-4,5-Dihydropyrazolo[3,4-C]Pyridine-3-Carboxamide; Eliquis; Unii-3Z9Y7Uwc1J; Bms-562247-01; Bms-562247
Brief Introduction
Apixaban (inn, trade name eliquis) is an anticoagulant used to prevent venous thromboembolism and atrial fibrillation stroke. It is a direct factor Xa inhibitor. Apixaban has been listed in Europe since May 2011. The drug was developed by a joint venture between Pfizer and Bristol Myers Squibb.
Suppliers
View More Vendors (2） >
CAS:571190-30-2
Molecular Formula:C24H29N7O2
Alias
More Information
Ibrance(Trade name); Pabcilib; Pabosi Ni
Brief Introduction
Pabcicilib is an inhibitor of cyclin dependent kinase (CDK) 4 and 6. Cyclin D1 and CDK4 / 6 are downstream signaling pathways leading to cell proliferation. In vitro, the proliferation of ER positive breast cancer cells was inhibited by blocking the progression from G1 to S phase. Compared with the treatment of each drug alone, the combination of pabacib and anti estrogen resulted in decreased phosphorylation of retinoblastoma protein (RB), decreased E2F expression and signal, and prevented growth. In vitro treatment of ER positive breast cancer cell lines with combination of pabacib and anti estrogen resulted in increased cell senescence, which lasted up to 6 days after drug removal.
Suppliers
View More Vendors (2） >
CAS:917389-32-3
Molecular Formula:C29H28F4N4O4
Alias
More Information
AIC246; CS-2799; MK-8828; UNII-1H09Y5WO1F; (4S)-8-Fluoro-3,4-Dihydro-2-[4-(3-Methoxyphenyl)-1-Piperazinyl]-3-[2-Methoxy-5-(Trifluoromethyl)Phenyl]-4-Quinazolineacetic acid; -Quinazolineacetic acid, 8-Fluoro-3,4-Dihydro-2-[4-(3-Methoxyphenyl)-1-Piperazinyl]-3-[2-Methoxy-5-(Trifluoromethyl)Phenyl]-, (4S)-
Brief Introduction
Letimovir is a novel anti CMV compound, which targets the virus terminal enzyme complex. Viruses resistant to DNA polymerase inhibitors also have activity.
Suppliers
View More Vendors (2） >
CAS:737789-87-6
Molecular Formula:C29H29F2N7O5S
Alias
More Information
1-(4-(1-(2,6-Difluorobenzyl)-5-((Dimethylamino)Methyl)-3-(6-Methoxypyridazin-3-yl)-2,4-Dioxo-1,2,3,4-Tetrahydrothieno[2,3-d]Pyrimidin-6-yl)Phenyl)-3-Methoxyurea; TAK-385
Brief Introduction
Relugolix is an oral gonadotropin releasing hormone receptor antagonist
Suppliers
View More Vendors (2） >
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!